Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2021-04-13FDA Approved: PROSCAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for PROSCAR (finasteride) from Organon LLC. The approval entails changes to the product's labeli…
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia. [Phase 4]
Phase 4 trial update evaluating efficacy and safety of a combination therapy for overactive bladder in male patients with benign prostatic h…
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: PROARTE -PROstate ARTery to Reduce the Symptoms of Benign Prostatic Hyperplasia [Phase 3]
Phase 3 clinical trial update for PROARTE aimed at reducing symptoms of benign prostatic hyperplasia and lower urinary tract symptoms; curre…
-
FDA approval · 2021-03-17FDA Approved: TADALAFIL — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for tadalafil from Cipla USA Inc. under ANDA210255, expanding the approved generic product for a…
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Rezum FIM Optimization Study [NA]
Completed clinical trial (Rezum FIM Optimization Study) for benign prostatic hyperplasia with results posted in 2021.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Rezum I Pilot Study for Benign Prostatic Hyperplasia [NA]
Pilot study update for Rezum procedure in Benign Prostatic Hyperplasia completed with results posted.
-
FDA approval · 2021-02-11FDA Approved: TADALAFIL — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for tadalafil from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: LC Bead LUMI for Prostatic Artery Embolization [NA]
A completed clinical trial evaluating LC Bead LUMI for prostatic artery embolization in benign prostatic hyperplasia (BPH) has results poste…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin [Phase 2]
Phase 2 study evaluating the effects of a single 100 mg dose of sildenafil on blood pressure and pulse rate in patients with benign prostati…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH) [Phase 4]
Phase 4 trial update evaluating effectiveness and safety of Viagra for erectile dysfunction in men with LUTS due to benign prostatic hyperpl…
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement [Phase 4]
Phase 4 trial evaluating the efficacy and safety of the Doxasozin GITS framework in patients with prostate enlargement has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH [Phase 3]
Phase 3 trial comparing prostatic artery embolization to pharmacotherapy for benign prostatic hyperplasia is reported as ongoing with status…
-
FDA approval · 2021-01-07FDA Approved: TADALAFIL — Supplemental Application (HEC Pharm USA Inc.)
The FDA approved a supplemental application for tadalafil from HEC Pharm USA Inc., indicating approval of an additional generic tadalafil pr…
-
FDA approval · 2020-12-29FDA Approved: JALYN — Supplemental Application (Waylis Therapeutics)
FDA approved a supplemental application for JALYN, a fixed-dose combination of dutasteride and tamsulosin hydrochloride, from Waylis Therape…
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: GreenLight XPS Laser System Retrospective Chart Review
Retrospective chart review of the GreenLight XPS laser system in benign prostatic hyperplasia has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: Intrathecal Versus Intravenous Dexmeditomedine in Transurethral Resection of the Prostate [Phase 4]
A Phase 4 clinical trial comparing intrathecal versus intravenous dexmedetomidine in patients undergoing transurethral resection of the pros…
-
FDA approval · 2020-10-27FDA Approved: N/A — Original Application (Bostal LLC)
FDA approved an original application for tadalafil (generic) by Bostal LLC under ANDA 208824.
-
FDA approval · 2020-10-23FDA Approved: DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for a generic combination product containing dutasteride and tamsulosin hydrochloride, manufactured …
-
FDA approval · 2020-10-23FDA Approved: TADALAFIL — Original Application (Umedica Laboratories USA Inc.)
FDA approved an original generic application for tadalafil (TADALAFIL) from Umedica Laboratories USA Inc.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enlargement [Phase 2]
Phase 2 clinical trial update evaluating a novel radiopaque embolic agent for prostatic artery embolisation in symptomatic benign prostatic …
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Bipolar Plasmakinetic TURP Vs Monopolar TURP in the Treatment of Lower Urinary Tract Symptoms [NA]
A completed clinical trial comparing Bipolar Plasmakinetic TURP to Monopolar TURP for lower urinary tract symptoms due to prostatic hyperpla…
-
FDA approval · 2020-10-01FDA Approved: ALFUZOSIN HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Alfuzosin hydrochloride submitted by Sun Pharmaceutical Industries, Inc. The document does n…
-
FDA approval · 2020-09-04FDA Approved: ALFUZOSIN HYDROCHLORIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approves a supplemental application for alfuzosin hydrochloride by Unichem Pharmaceuticals (USA), Inc., confirming its status as an appr…
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System vs TURP for the Treatment of BPH [NA]
A completed clinical trial comparing photoselective vaporization of the prostate using the GreenLight XPS laser system to TURP for benign pr…
-
FDA approval · 2020-07-22FDA Approved: DUTASTERIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for a generic dutasteride product manufactured by Amneal Pharmaceuticals LLC.